154 related articles for article (PubMed ID: 23277051)
1. Suppressors of cytokine signalling-3 and -1 in human carcinogenesis.
Culig Z
Front Biosci (Schol Ed); 2013 Jan; 5(1):277-83. PubMed ID: 23277051
[TBL] [Abstract][Full Text] [Related]
2. A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.
Qiu X; Guo G; Chen K; Kashiwada M; Druker BJ; Rothman PB; Chen JL
Neoplasia; 2012 Jun; 14(6):547-58. PubMed ID: 22787435
[TBL] [Abstract][Full Text] [Related]
3. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
5. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.
Neuwirt H; Puhr M; Santer FR; Susani M; Doppler W; Marcias G; Rauch V; Brugger M; Hobisch A; Kenner L; Culig Z
Am J Pathol; 2009 May; 174(5):1921-30. PubMed ID: 19342366
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways.
Puhr M; Santer FR; Neuwirt H; Susani M; Nemeth JA; Hobisch A; Kenner L; Culig Z
Cancer Res; 2009 Sep; 69(18):7375-84. PubMed ID: 19738059
[TBL] [Abstract][Full Text] [Related]
8. Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells.
Kuo PL; Ni WC; Tsai EM; Hsu YL
Mol Cancer Ther; 2009 May; 8(5):1328-39. PubMed ID: 19383849
[TBL] [Abstract][Full Text] [Related]
9. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion.
Neuwirt H; Puhr M; Cavarretta IT; Mitterberger M; Hobisch A; Culig Z
Endocr Relat Cancer; 2007 Dec; 14(4):1007-19. PubMed ID: 18045952
[TBL] [Abstract][Full Text] [Related]
11. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
[TBL] [Abstract][Full Text] [Related]
12. The suppressors of cytokine signalling (SOCS).
Kile BT; Alexander WS
Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the roles of suppressor of cytokine signaling-3 in prostate cancer development and progression.
Fu X; Ren L; Chen J; Liao K; Fu Y; Qian X; Xiao J
Asia Pac J Clin Oncol; 2015 Jun; 11(2):106-13. PubMed ID: 25899712
[TBL] [Abstract][Full Text] [Related]
14. Suppressors of cytokine signaling (SOCS) and type 2 diabetes.
Feng X; Tang H; Leng J; Jiang Q
Mol Biol Rep; 2014; 41(4):2265-74. PubMed ID: 24414000
[TBL] [Abstract][Full Text] [Related]
15. Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma.
Tischoff I; Hengge UR; Vieth M; Ell C; Stolte M; Weber A; Schmidt WE; Tannapfel A
Gut; 2007 Aug; 56(8):1047-53. PubMed ID: 17376806
[TBL] [Abstract][Full Text] [Related]
16. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer.
Bellezza I; Neuwirt H; Nemes C; Cavarretta IT; Puhr M; Steiner H; Minelli A; Bartsch G; Offner F; Hobisch A; Doppler W; Culig Z
Am J Pathol; 2006 Dec; 169(6):2199-208. PubMed ID: 17148681
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
19. Suppressors of cytokine signalling: SOCS.
Larsen L; Röpke C
APMIS; 2002 Dec; 110(12):833-44. PubMed ID: 12645661
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
Valentino L; Pierre J
Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
